Your cart is empty.
Scientists from Affymetrix, Inc., a world-leading supplier of microarray equipment and assays, have compared the performance of Tecan’s Infinite 200 NanoQuant multimode microplate reader with other instruments on the market for low volume DNA concentration analysis. Dr Jim Collins, Director of Assay Development, explained: “We have recently developed a new generation of general cytogenetic assay, requiring precise spectrophotometric quantification of small volumes of DNA. I have always been highly impressed with the quality of instrumentation from Tecan in terms of its robustness and reliability, and the Infinite 200 NanoQuant offers higher throughput than anything else available for quantification of low volumes, making it highly suitable for this assay.”
Vicky Huynh, Jim’s colleague who carried out the evaluation, explained: “The Infinite 200 NanoQuant is a fantastic addition to our laboratory. It is quick, and the software is very easy to use. The NanoQuant Plate™ is compatible with multichannel pipettes for high throughput, and quantification of whole microplates only takes a few minutes. The easy-to-clean plate helps to eliminate cross-contamination and there is no need to dilute samples. It is ideal for both high and low throughput, processing batches of sixteen samples in just one minute with high reproducibility.”
To find out more on Tecan’s Infinite 200 NanoQuant, visit www.tecan.com/nanoquant
For more information about Tecan, please contact:
Tecan Group Ltd
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).